Replies to post #109610 on NanoViricides Inc. (NNVC)

[winstreak]

I say 2.

Since Nanoviricides informed us they intend to get into a rhythm of a new drug in human trials every six months, I figure two will do.

I expect 1 drug in the first year or maybe first two years, then as they improve their knowledge of procedures, processes, experience, and supply chains; they'll get their ducks in a row and get two in per year.

Remember, they are working on getting a platform approved that will make each drugs approval that much easier. I suggest even a unique path through FDA approval may be established when all the dust settles due to the "cookie cutter" manner in which these drugs are created. Similar to the way flu vaccines are done each year, perhaps.

[drkazmd65]

Short answer - as many as can be profitably designed, proofed, scaled-up, clinically tested, manufactured and distributed.

With this caveat - that until Flucide is actually in Clinical Trials, no other proposed 'Cide should be moved beyond the beginnings of the 'scaled-up' stage.

Let Dr. Diawan and his R&D guys think up, model, and continue to find partner labs to do the Pre-Clinical testing as much as they want. That part of the process is relatively cheap, and relatively easy to do. It'll make sure that the 'next' 'Cide is always ready to move down the pipeline as Flucide, then as Denguecide, MERScide, Oral Flucide,.... move into production (one at a time) - keep that pipeline full behind them.

One thing in production and scale-up at a time though as while the Shelton plant will have much greater capacity for production than did the old R&D lab - it's got limits, and there is at present still a fairly limited crew there to keep things going.

The future continues to look bright - just got to get past that first big revenue generating hump.